Prelude Capital Management’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1740 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1997 |
|
|
2020
Q1 | – | Sell |
-340
| Closed | -$9K | – | 1721 |
|
|
2019
Q4 | $9K | Sell |
340
-38
| -10% | -$1.01K | ﹤0.01% | 1254 |
|
|
2019
Q3 | $8K | Sell |
378
-442
| -54% | -$9.35K | ﹤0.01% | 1033 |
|
|
2019
Q2 | $26K | Buy |
820
+64
| +8% | +$2.03K | ﹤0.01% | 892 |
|
|
2019
Q1 | $24K | Sell |
756
-102
| -12% | -$3.24K | ﹤0.01% | 928 |
|
|
2018
Q4 | $21K | Sell |
858
-1,530
| -64% | -$37.4K | ﹤0.01% | 924 |
|
|
2018
Q3 | $79K | Buy |
2,388
+358
| +18% | +$11.8K | ﹤0.01% | 726 |
|
|
2018
Q2 | $72K | Sell |
2,030
-533
| -21% | -$18.9K | ﹤0.01% | 799 |
|
|
2018
Q1 | $83K | Buy |
2,563
+563
| +28% | +$18.2K | 0.01% | 818 |
|
|
2017
Q4 | $51K | Buy |
+2,000
| New | +$51K | ﹤0.01% | 829 |
|